WCG's 360 Protocol Assessment™ is an integrated, turn-key solution that addresses ICH E8 R1 expectations and improves clinical trial predictability by providing sponsors with an operational risk and feasibility assessment of the protocol through the lens of multi-functional stakeholders [...]
Read MoreMay 21-24, 2023 | Philadelphia, PA
Join WCG Avoca's Trevor Cole for the session: "What to Expect When You’re Inspected: Site FDA Inspection Readiness and Logistics"
May 17-18, 2023 | Industry-wide Virtual Event
Now in its 12th year, the Summit features expert speakers, executive panels, and perspectives from all stakeholders across the clinical trial ecosystem.
The survey is closed – thank you for your participation!
WCG Avoca takes pride in providing the industry with insights into trends in clinical research to optimize the execution and quality of clinical trials. This year, our research looks to analyze across clinical research stakeholders […]
February 6-9, 2023 | Orlando, FL + Virtual
Join WCG Avoca's Kristen Bennett for the session: "Principles of RBQM Success: Why It’s Important and What Happens Without an RBQM Program"
January 24, 2023 | 2:00pm – 3:00pm EST
In addition to WCG's 2023 Clinical Research Trends & Insights report, an online panel of clinical trial experts including WCG Avoca's Cristin MacDonald, PhD, discuss the future of clinical research.
January 18, 2023 | 11:00am – 12:00pm EST
In this webinar, WCG Avoca and Medable address how the clinical trial ecosystem can work together to alleviate the site burdens that come along with DCT implementation.
With the update of the Bioresearch Monitoring Program (BIMO) Sponsors and Contract Research Organizations Compliance Program Manual, FDA provides a comprehensive overview of inspection activities with significant revisions to Part III–Inspectional section […]
Read More